Clinical Trial Update: Dimebon (PF-01913539)-Digoxin Drug-Drug Interaction Study In Healthy Subjects [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update evaluating the drug-drug interaction between Dimebon (PF-01913539) and digoxin in healthy subjects, completed by Pfizer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Huntington Disease

Drugs mentioned

• DIGOXIN (Digoxin)
• Dimebon (latrepirdine)

Snippet

Sponsor: Pfizer | Conditions: Alzheimer Disease, Huntington Disease | Phase 1 | Status: COMPLETED